Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.58T | 1.50T | 1.38T | 1.35T | 1.21T |
Gross Profit | 417.96B | 392.27B | 397.04B | 374.76B | 317.76B |
EBITDA | 469.56B | 375.79B | 393.33B | 373.10B | 316.52B |
Net Income | 189.36B | 168.43B | 165.34B | 155.17B | 135.66B |
Balance Sheet | |||||
Total Assets | 8.00T | 7.58T | 6.87T | 6.49T | 6.07T |
Cash, Cash Equivalents and Short-Term Investments | 1.32T | 278.70B | 945.00B | 861.92B | 670.85B |
Total Debt | 3.34T | 3.14T | 2.87T | 2.74T | 2.52T |
Total Liabilities | 5.26T | 4.96T | 4.49T | 4.26T | 4.01T |
Stockholders Equity | 2.56T | 2.40T | 2.16T | 2.00T | 1.85T |
Cash Flow | |||||
Free Cash Flow | -119.69B | -144.15B | -16.61B | -49.02B | -112.43B |
Operating Cash Flow | 324.12B | 307.25B | 269.91B | 280.09B | 207.41B |
Investing Cash Flow | -361.50B | -362.02B | -312.05B | -313.78B | -297.30B |
Financing Cash Flow | 12.87B | 100.43B | 30.46B | 90.97B | 50.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $29.12B | 25.47 | 9.67% | 3.39% | 5.61% | 19.66% | |
74 Outperform | $22.88B | 18.82 | 7.53% | 0.05% | 0.09% | 9.91% | |
73 Outperform | $19.91B | 94.53 | 4.92% | 3.54% | 6.11% | -37.43% | |
68 Neutral | $18.83B | 51.80 | 3.71% | 3.16% | -6.56% | -54.29% | |
68 Neutral | $19.47B | 27.95 | 12.09% | 3.44% | 7.61% | 27.83% | |
64 Neutral | $6.89B | 17.45 | -1.92% | 7.02% | 4.59% | -24.66% | |
62 Neutral | $18.35B | 31.79 | 9.37% | 3.94% | 1.55% | 0.73% |